Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic, Wegovy, ...

Other GLP1-RA include the compounds dulaglutide and liraglutide. These contain active ingredients such as semaglutide and dulaglutide and are considered an advancement in weight management and the ...

Medically reviewed by Lindsay Cook, PharmD Trulicity (dulaglutide) and Ozempic (semaglutide) are medications used to manage high blood sugar levels associated with type 2 diabetes. They are classified ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...